We will be present at SIBS in Zurich, the international conference on Image-Based Screening. The program is plenty of interesting talks on “model systems in screening”, “advances in screening technology and assay”, or “images and data analysis”.

Furthermore, Nathalie, our CEO, is invited to present our activities on phenotypic screening on our innovative 3D culture assays. She will present you our activities, especially on our advances regarding the differentiation of patient-derived induced pluripotent stem cells for phenotypic screening in metabolic diseases. Furthermore, she will explain our vision on how new technologies, as virtual and augmented realities, deep learning and machine learning can be an advantage in phenotypic screening.

Nathalie hopes to see you in this congress to discuss on these topics! If you want to schedule a appointment, contact us.


Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

Leave a Reply